Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 181 - 200 of 216
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Oct 2013, 10:57 am by Peter Tillers
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 599 (1993) (Rehnquist, C.J., concurring in part and dissenting in part) (“the various briefs filed in this case … deal with definitions of scientific knowledge, scientific method, scientific validity, and peer review—in short, matters far afield from the expertise of judges”); Marconi Wireless Telegraph Co. [read post]
10 Sep 2014, 9:00 am by Maureen Johnston
Merrell Dow Pharmaceuticals regarding important expert testimony requires the appellate court to order a new trial, regardless of whether there was actually any substantive error in the expert testimony heard or not heard by the jury. [read post]
20 Apr 2017, 8:23 am by Elizabeth Kruska
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579(1993). [read post]
13 Apr 2007, 8:09 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Frye v. [read post]
31 Oct 2018, 10:04 am by Schachtman
In some instances, especially in studies pharmaceutical adverse outcomes, there is the danger that the hypothesized outcome is also a feature of the underlying disease being treated. [read post]
10 Jun 2012, 1:09 pm by Schachtman
Merrell Dow Pharms., Inc., 874 F.2d 307, 311 (5th Cir. 1989) (noting that “[o]ne difficulty with epidemiologic studies is that often several factors can cause the same disease. [read post]
6 May 2010, 4:12 pm by Bexis
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
31 Jan 2014, 7:11 am by John Elwood
Merrell Dow Pharmaceuticals, Inc. [read post]
1 Jun 2014, 7:45 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Wilt v. [read post]
12 Nov 2014, 8:01 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 599 (1993) (Rehnquist, C.J., concurring in part and dissenting in part) (‘‘the various briefs filed in this case … deal with definitions of scientific knowledge, scientific method, scientific validity, and peer review—in short, matters far afield from the expertise of judges’’); Marconi Wireless Telegraph Co. of America v. [read post]
22 Dec 2009, 8:57 pm
Digital Sys., Inc. v. [read post]
6 Feb 2014, 6:31 am by RatnerPrestia
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), and need not find facts when evidence is disputed in these cases.[10] In 2005, the Federal Circuit sat en banc in Phillips. [read post]
18 Sep 2019, 10:02 am by centrallaw
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
17 Jun 2021, 12:29 pm by admin
As a result, so-called Daubert hearings began taking place in district courts around the country, in parallel with other centralized proceedings in MDL 926. [read post]
17 Jul 2010, 10:13 pm by aaronklaw
For example, an Arizona jury awarded a homeowner and his family more than $4 million for a case where the insurance carrier delayed remediating mold contamination (Hatley v. [read post]